Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
05.11. | Benchmark Holdings plc: Rule 2.9 Announcement | 1 | Oslo Børs | ||
05.11. | Benchmark Hlgs PLC - Rule 2.9 Announcement | - | RNS | ||
31.10. | Benchmark Holdings plc: Total Voting Rights | 1 | Oslo Børs | ||
31.10. | Benchmark Hlgs PLC - Total Voting Rights | - | RNS | ||
21.10. | Benchmark Holdings plc: Financial calendar | 2 | Oslo Børs | ||
BENCHMARK HOLDINGS Aktie jetzt für 0€ handeln | |||||
30.09. | Benchmark Holdings plc: Total Voting Rights | 2 | Oslo Børs | ||
30.09. | Benchmark Hlgs PLC - Total Voting Rights | - | RNS | ||
02.09. | Benchmark Holdings plc: Rule 2.9 Announcement | - | Oslo Børs | ||
02.09. | Benchmark Hlgs PLC - Rule 2.9 Announcement | 1 | RNS | ||
30.08. | Benchmark Holdings plc: Total Voting Rights | 1 | Oslo Børs | ||
30.08. | Benchmark Hlgs PLC - Total Voting Rights | - | RNS | ||
22.08. | Benchmark Holdings quarterly loss widens amid restructuring efforts | 1 | Alliance News | ||
22.08. | Waiting game: Benchmark Holdings' revenue dips as London escape bid continues | 1 | City A.M. | ||
22.08. | Benchmark Hlgs PLC - Q3 Results | - | RNS | ||
07.08. | Benchmark Holdings plc: Notice of Q3 Results | 1 | Oslo Børs | ||
05.08. | Benchmark Hlgs PLC - Notice of Q3 Results | - | RNS | ||
31.07. | Benchmark Holdings plc: Total Voting Rights | 1 | Oslo Børs | ||
31.07. | Benchmark Hlgs PLC - Total Voting Rights | - | RNS | ||
10.07. | Benchmark Holdings plc: Rule 2.9 Announcement | 1 | Oslo Børs | ||
10.07. | Benchmark Hlgs PLC - Rule 2.9 Announcement | - | RNS |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
BAYER | 19,802 | +1,46 % | DAX-Check LIVE: Adesso, Allianz, Bayer, Conti, GFT, Porsche SE, Rheinmetall, Siemens Energy, Thyssen | Vor dem Wochenende verzeichnete der DAX leichte Verluste in Höhe von knapp 0,3 Prozent. Auf Wochensicht bewegte sich der deutsche Leitindex jedoch abermals kaum vom Fleck. Worauf es jetzt für den DAX... ► Artikel lesen | |
NOVO NORDISK | 100,92 | +0,20 % | Novo Nordisk, BioNxt Solutions, Bavarian Nordic - Chancen nach der Horror-Woche | Die abgelaufene Börsenwoche war eine zum Vergessen für den Biotech- und Medtechsektor. Durch die Nominierung des impfkritischen Robert F. Kennedy als zukünftigen US-Gesundheitsministers verloren Aktien... ► Artikel lesen | |
GSK | 16,295 | +2,65 % | GSK Plc Announces Regulatory Expansion For Arexvy In Japan To Include Adults Aged 50-59 | BRUSSELS/FRANKFURT/PARIS (dpa-AFX) - GSK plc (GSK, GSK.L) announced that Japan's Ministry of Health, Labour and Welfare has approved a regulatory application to extend the indication of Arexvy... ► Artikel lesen | |
INNOCAN PHARMA | 0,148 | -1,67 % | Breaking News: InnoCan Pharma erzielt 24 Mio. USD Umsatz… | ||
TRANSCANNA | 0,017 | -100,00 % | XFRA DELETION OF INSTRUMENTS FROM XETRA - 02.07.2024 | The following instruments on XETRA do have their last trading day on 02.07.2024Die folgenden Instrumente in XETRA haben ihren letzten Handelstag am 02.07.2024ISIN NameGB00BMGRFP88 CITIUS RESOURCES LS-... ► Artikel lesen | |
EYEPOINT PHARMACEUTICALS | 8,616 | +0,42 % | EyePoint Pharmaceuticals, Inc.: EyePoint Pharmaceuticals Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4) | WATERTOWN, Mass., Nov. 18, 2024 (GLOBE NEWSWIRE) -- EyePoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a company committed to developing and commercializing therapeutics to help improve the lives of patients... ► Artikel lesen | |
EDWARDS LIFESCIENCES | 67,84 | +0,25 % | Edwards Lifesciences-Aktie legt um 4,75 Prozent zu (67,0318 €) | Der Anteilsschein von Edwards Lifesciences notiert am Montag fester. Das Papier notiert aktuell bei 70,98 US-Dollar. Eine Verteuerung in Höhe von 3,22 US-Dollar erfreut derzeit die Aktionäre von Edwards... ► Artikel lesen | |
MYDECINE INNOVATIONS GROUP | 0,003 | 0,00 % | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements | Mydecine Innovations Group Inc - Mydecine Announces Filing of Q3 Financial Statements
PR Newswire
LONDON, United Kingdom, November 21
MYDECINE ANNOUNCES FILING OF Q3 FINANCIAL... ► Artikel lesen | |
HAPPY BELLY FOOD GROUP | 0,550 | 0,00 % | Happy Belly Food Group Inc.: Happy Belly's HEAL Wellness QSR Announces the Opening of Its Newest Location in Edmonton's North Town Center | Toronto, Ontario--(Newsfile Corp. - November 22, 2024) - Happy Belly Food Group Inc. (CSE: HBFG) (OTCQB: HBFGF) ("Happy Belly" or the "Company"), a leading consolidator of emerging food brands is pleased... ► Artikel lesen | |
CHRISTINA LAKE CANNABIS | 0,019 | 0,00 % | Christina Lake Cannabis Corp: Christina Lake to complete $3.6M private placement | ||
PSYCHED WELLNESS | 0,010 | 0,00 % | Psyched Wellness Ltd.: Psyched Wellness Announces Supply Chain Disruption in the US | Toronto, Ontario--(Newsfile Corp. - August 6, 2024) - Psyched Wellness Ltd. (CSE: PSYC) (OTCQB: PSYCF) (FSE: 5U9) ("Psyched"), a life sciences company focused on the production and distribution of... ► Artikel lesen | |
JAZZ PHARMACEUTICALS | 122,05 | +0,33 % | Jazz Pharmaceuticals plc: Jazz Pharmaceuticals Announces U.S. FDA Approval of Ziihera (zanidatamab-hrii) for the Treatment of Adults with Previously Treated, Unresectable or Metastatic HER2-positive (IHC 3+) Biliary Tract ... | Ziihera is the first and only dual HER2-targeted bispecific antibody approved for HER2+ BTC in the U.S.Ziihera received accelerated approval based on results including a 52% objective response... ► Artikel lesen | |
DAIICHI SANKYO | 27,600 | -0,90 % | EQS-News: Daiichi Sankyo Deutschland GmbH: Die Investitionen von Daiichi Sankyo in Krebsmedikamente nehmen Gestalt an: Zum Baubeginn des Produktionsgebäudes besucht Ministerpräsident Söder das Werk in Pfaffenhofen | Emittent / Herausgeber: Daiichi Sankyo Deutschland GmbH
/ Schlagwort(e): Expansion
Die Investitionen von Daiichi Sankyo in Krebsmedikamente nehmen Gestalt an: Zum Baubeginn des... ► Artikel lesen | |
SWEET EARTH | 0,010 | 0,00 % | Sweet Earth Holdings Corp (3): Sweet Earth Holdings closes $204,000 private placement |